Dr. Zahrah Meher Taufique, M.D. Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 134 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-9363 |
Dr. Alec Ebraim Vaezi, M.D., PH.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 120 Mineola Blvd Ste 320, Mineola, NY 11501 Phone: 516-663-2436 Fax: 516-663-2780 |
Dr. Maseih Moghaddassi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 134 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-9363 Fax: 516-294-9228 |
Dr. Alfred Andrew Adamo, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Not Enrolled in Medicare Practice Location: 120 Mineola Blvd, Suite 320, Mineola, NY 11501 Phone: 516-663-3300 Fax: 516-663-2780 |
Dr. Anthony J Durante, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 134 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-9363 Fax: 516-294-6228 |
Dr. Emil Ganjian, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 134 Mineola Blvd, Mineola, NY 11501 Phone: 516-294-9363 Fax: 516-294-6228 |
News Archive
Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.
Encouraged by early results of a study of an experimental malaria vaccine involving 45 children in Burkina Faso, researchers led by Pierre Druilhe at the Pasteur Institute in Paris are set to expand the clinical trial, resulting in a larger study involving 800 children in Mali, BBC News reports.
A case of cystic colonic duplication in an adult mimicked a tumor of the pancreas and the diagnosis was established by histopathological examination of the resected specimen after distal pancreatectomy.
Competitive Technologies, Inc. today announced that it has signed an agreement to raise over $5 million by selling 2 million shares of equity to Crisnic Fund, S.A. based on a 15% discount from the volume weighted average price on the date the SEC declares the registration effective, as detailed in the 8-K being filed today.
› Verified 9 days ago